SLC26A4 expression among autoimmune thyroid tissues

Immunobiology

Volumn 216, Issue 5, 2011, Pages 571-578

  Belguith Maalej, Salima ^a,d   Rebuffat, Sandra A ^b,d   Charfeddine, Ilhem ^c   Mnif, Mouna ^c,d   Nadir, R Farid ^e   Abid, Mohamed ^c   Ghorbel, Abdelmoneem ^c   Peraldi Roux, Sylvie ^b,d   Ayadi, Hammadi ^a,d   Hadj Kacem, Hassen ^a,d  

^a CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^b CNRS   (France)

^c HABIB BOURGUIBA HOSPITAL   (Tunisia)

^d Laboratoire International Associé LIA 135   (Tunisia)

^e The London Endocrine Clinic   (United Kingdom)

Author keywords

Autoimmune thyroid diseases; Graves' disease; Hashimoto thyroiditis; Immunofluorescence; Pendrin; Real time PCR

Indexed keywords

PENDRIN; THYROGLOBULIN; THYROTROPIN;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GENE EXPRESSION; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNODETECTION; IMMUNOFLUORESCENCE TEST; IMMUNOLOCALIZATION; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA;

CARCINOMA; CELLS, CULTURED; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MEMBRANE TRANSPORT PROTEINS; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; THYROTROPIN; TUNISIA;

EID: 79953274323     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.09.015     Document Type: Article

References (59)

1. Adler L., Efrati E., Zelikovic I. Molecular mechanisms of epithelial cell-specific expression and regulation of the human anion exchanger (pendrin) gene. Am. J. Physiol. Cell. Physiol. 2008, 294:1261-1276.
2. Ambesi-Impiombato F.S., Parks L.A., Coon H.G. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:3455-3459.
3. Arturi F., Russo D., Bidart J.M., Scarpelli D., Schlumberger M., Filetti S. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. Eur. J. Endocrinol. 2001, 145:129-135.
4. Belguith-Maalej S., Hadj-Kacem H., Rebuffat S.A., Mnif-Feki M., Nguyen B., Abid M., Gross R., Ayadi H., Peraldi-Roux S. Absence of anti-Pendrin auto-antibodies in the sera of Tunisian patients with autoimmune thyroid disease. Clin Lab. 2010, 56:335-343.
5. Bidart J.M., Mian C., Lazar V., Russo D., Filetti S., Caillou B., Schlumberger M. Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J. Clin. Endocrinol. Metab. 2000, 85:2028-2033.
6. Bizhanova A., Kopp P. Minireview: the sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 2009, 150:1084-1090.
7. Bruno R., Ferretti E., Tosi E., Arturi F., Giannasio P., Mattei T., Scipioni A., Presta I., Morisi R., Gulino A., Filetti S., Russo D. Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin. J. Clin. Endocrinol. Metab. 2005, 90:5692-5697.
8. Choi B.Y., Stewart A.K., Madeo A.C., Pryor S.P., Lenhard S., Kittles R., Eisenman D., Kim H.J., Niparko J., Thomsen J., Arnos K.S., Nance W.E., King K.A., Zalewski C.K., Brewer C.C., Shawker T., Reynolds J.C., Butman J.A., Karniski L.P., Alper S.L., Griffith A.J. Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms?. Hum. Mutat. 2009, 30:599-608.
9. Choi B.Y., Alper S.L., Griffith A.J. Response to: the c.-103T>C variant in the 5'-UTR of SLC26A4 gene: a pathogenic mutation or coincidental polymorphism?. Hum. Mutat. 2009, 30:1471.
10. Cremers C.W., Admiraal R.J., Huygen P.L., Bolder C., Everett L.A., Joosten F.B., Green E.D., Van Camp G., Otten B.J. Progressive hearing loss, hypoplasia of the cochlea and widened vestibular aqueducts are very common features in Pendred's syndrome. Int. J. Pediatr. Otorhinolaryngol. 1998, 45:113-123.
11. De Micco C., Kopp F., Vassko V., Grino M. In situ hybridization and immunohistochemistry study of thyroid peroxidase expression in thyroid tumors. Thyroid 2000, 10:109-115.
12. De Micco C., Ruf J., Chrestian M.A., Gros N., Henry J.F., Carayon P. Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues. Cancer 1991, 67:3036-3041.
13. Dentice M., Luongo C., Elefante A., Ambrosio R., Salzano S., Zannini M., Nitsch R., Di Lauro R., Rossi G., Fenzi G., Salvatore D. Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol. Cell. Biol. 2005, 25:10171-10182.
14. Estienne V., Duthoit C., Reichert M., Praetor A., Carayon P., Hunziker W., Ruf J. Androgen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves' disease: a possible molecular clue for sex dependence of autoimmune disease. FASEB J. 2002, 16:1087-1092.
15. Everett L.A., Glaser B., Beck J.C., Idol J.R., Buchs A., Heyman M., Adawi F., Hazani E., Nassir E., Baxevanis A.D., Sheffield V.C., Green E.D. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet. 1997, 17:411-422.
16. Everett L.A., Morsli H., Wu D.K., Green E.D. Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9727-9732.
17. Fraser G.R. Association of congenital deafness with goitre (Pendred's syndrome): a study of 207 families. Ann. Hum. Genet. 1965, 28:201-249.
18. Friis J., Johnsen T., Feldt-Rasmussen U., Bech K., Friis T. Thyroid function in patients with Pendred's syndrome. J. Endocrinol. Invest. 1988, 11:97-101.
19. Gerard A.C., Daumerie C., Mestdagh C., Gohy S., De Burbure C., Costagliola S., Miot F., Nollevaux M.C., Denef J.F., Rahier J., Franc B., De Vijlder J.J., Colin I.M., Many M.C. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J. Clin. Endocrinol. Metab. 2003, 88:4977-4983.
20. Gillam M.P., Sidhaye A.R., Lee E.J., Rutishauser J., Stephan C.W., Kopp P. Functional characterization of pendrin in a polarized cell system: evidence for pendrin-mediated apical iodide efflux. J. Biol. Chem. 2004, 279:13004-13010.
21. Hadj Kacem H., Rebai A., Kaffel N., Masmoudi S., Abid M., Ayadi H. PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study. J. Clin. Endocrinol. Metab. 2003, 88:2274-2280.
22. Hedinger C., Williams E.D., Sobin L.H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989, 63:908-911.
23. Hermanek P., Sobin L.H. Thyroid Gland (ICD-Oc73): TNM Classification of Malignant Tumors 1992, Springer-Verlag, Berlin, pp. 35-37. 4th ed.
24. Ibrahim I.M., McDonald D.O., Owen C.J., Kendall-Taylor P., Pearce S.H.S. Graves' hyperthyroidism in a patient with pendred's dyshormonogenesis. Hot. Thyroidol. 2009, 13:09.
25. Kohn L.D., Suzuki K., Nakazato M., Royaux I.E., Green E.D. Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte. Trends Endocrinol. Metab. 2001, 12:10-16.
26. Kondo T., Nakamura N., Suzuki K., Murata S.I., Muramatsu A., Kawaoi A., Katoh R. Expression of human pendrin in diseased thyroids. J. Histochem. Cytochem. 2003, 51:167-173.
27. Lacroix L., Mian C., Caillou B., Talbot M., Filetti S., Schlumberger M., Bidart J.M. Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur. J. Endocrinol. 2001, 144:297-302.
28. Mian C., Lacroix L., Alzieu L., Nocera M., Talbot M., Bidart J.M., Schlumberger M., Caillou B. Sodium iodide symporter and pendrin expression in human thyroid tissues. Thyroid 2001, 11:825-830.
29. Muscella A., Marsigliante S., Verri T., Urso L., Dimitri C., Bottà G., Paulmichl M., Beck-Peccoz P., Fugazzola L., Storelli C. PKC-epsilon-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PCCl3 cells. J. Cell. Physiol. 2008, 217:103-112.
30. Noguchi Y., Harii N., Giuliani C., Tatsuno I., Suzuki K., Kohn L.D. Thyroglobulin (Tg) induces thyroid cell growth in a concentration-specific manner by a mechanism other than thyrotropin/cAMP stimulation. Biochem. Biophys. Res. Commun. 2009, 391:890-894.
31. Pendred V. Deaf mutism and goitre. Lancet 1896, 11:532.
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
33. ©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30(9):e36.
34. Porra V., Bernier-Valentin F., Trouttet-Masson S., Berger-Dutrieux N., Peix J.L., Perrin A., Selmi-Ruby S., Rousset B. Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues. J. Clin. Endocrinol. Metab. 2002, 87:1700-1707.
35. Porra V., Ferraro-Peyret C., Durand C., Selmi-Ruby S., Giroud H., Berger-Dutrieux N., Decaussin M., Peix J.L., Bournaud C., Orgiazzi J., Borson-Chazot F., Dante R., Rousset B. Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas. J. Clin. Endocrinol. Metab. 2005, 90:3028-3035.
36. Reardon W., Trembath R.C. Pendred syndrome. J. Med. Genet. 1996, 33:1037-1040.
37. Reardon W., Coffey R., Chowdhury T., Grossman A., Jan H., Britton K., Kendall-Taylor P., Trembath R. Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome. J. Med. Genet. 1999, 36:595-598.
38. Reardon W., Coffey R., Phelps P.D., Luxon L.M., Stephens D., Kendall-Taylor P., Britton K.E., Grossman A., Trembath R. Pendred syndrome-100 years of under ascertainment. Quart. J. Med. 1997, 90:443-447.
39. Rillema J.A., Hill M.A. Prolactin regulation of the pendrin-iodide transporter in the mammary gland. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E25-E28.
40. Rodriguez A.M., Perron B., Lacroix L., Caillou B., Leblanc G., Schlumberger M., Bidart J.M., Pourcher T. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J. Clin. Endocrinol. Metab. 2002, 87:3500-3503.
41. Rotman-Pikielny P., Hirschberg K., Maruvada P., Suzuki K., Royaux I.E., Green E.D., Kohn L.D., Lippincott-Schwartz J., Yen P.M. Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. Hum. Mol. Genet. 2002, 11:2625-2633.
42. Royaux I.E., Belyantseva I.A., Wu T., Kachar B., Everett L.A., Marcus D.C., Green E.D. Localization and functional studies of pendrin in the mouse inner ear provide insight about the etiology of deafness in Pendred syndrome. J. Assoc. Res. Otolaryngol. 2003, 4:394-404.
43. Royaux I.E., Suzuki K., Mori A., Katoh R., Everett L.A., Kohn L.D., Green E.D. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 2000, 141:839-845.
44. Royaux I.E., Wall S.M., Karniski L.P., Everett L.A., Suzuki K., Knepper M.A., Green E.D. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4221-4226.
45. Rozen S., Skaletsky H.J. Primer 3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000, 365-386. Humana Press, Totowa, NJ. S. Krawetz, S. Misener (Eds.).
46. Ruf J., Toubert M.E., Czarnocka B., Durand-Gorde J.M., Ferrand M., Carayon P. Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 1989, 125:1211-1218.
47. Russo D., Bulotta S., Bruno R., Arturi F., Giannasio P., Derwahl M., Bidart J.M., Schlumberger M., Filetti S. Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter. Eur. J. Endocrinol. 2001, 145:591-597.
48. Scott D.A., Wang R., Kreman T.M., Andrews M., McDonald J.M., Bishop J.R., Smith R.J., Karniski L.P., Sheffield V.C. Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum. Mol. Genet. 2000, 9:1709-1715.
49. Scott D.A., Wang R., Kreman T.M., Sheffield V.C., Karniski L.P. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat. Genet. 1999, 21:440-443.
50. Skubis-Zegadło J., Nikodemska A., Przytuła E., Mikula M., Bardadin K., Ostrowski J., Wenzel B.E., Czarnocka B. Expression of pendrin in benign and malignant human thyroid tissues. Br. J. Cancer 2005, 93:144-151.
51. Suzuki K., Kohn L.D. Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J. Endocrinol. 2006, 189:247-255.
52. Suzuki K., Royaux I.E., Everett L.A., Mori-Aoki A., Suzuki S., Nakamura K., Sakai T., Katoh R., Toda S., Green E.D., Kohn L.D. Expression of PDS/Pds, the Pendred syndrome gene, in endometrium. J. Clin. Endocrinol. Metab. 2002, 87:938.
53. Taylor J.P., Metcalfe R.A., Watson P.F., Weetman A.P., Trembath R.C. Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndrome. J. Clin. Endocrinol. Metab. 2002, 87:1778-1784.
54. Vaidya B., Coffey R., Coyle B., Trembath R., San Lazaro C., Reardon W., Kendall-Taylor P. Concurrence of Pendred syndrome, autoimmune thyroiditis, and simple goiter in one family. J. Clin. Endocrinol. Metab. 1999, 84:2736-2738.
55. Wangemann P., Itza E.M., Albrecht B., Wu T., Jabba S.V., Maganti R.J., Lee J.H., Everett L.A., Wall S.M., Royaux I.E., Green E.D., Marcus D.C. Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med. 2004, 2:30.
56. Yang T., Smith R.J. The c.-103T>C variant in the 5'-UTR of SLC26A4 gene: a pathogenic mutation or coincidental polymorphism?. Hum. Mutat. 2009, 30:1469-1470.
57. Yang T., Vidarsson H., Rodrigo-Blomqvist S., Rosengren S.S., Enerback S., Smith R.J. Transcriptional control of SLC26A4 is involved in Pendred syndrome and nonsyndromic enlargement of vestibular aqueduct (DFNB4). Am. J. Hum. Genet. 2007, 80:1055-1063.
58. Yoon J.S., Park H.J., Yoo S.Y., Namkung W., Jo M.J., Koo S.K., Park H.Y., Lee W.S., Kim K.H., Lee M.G. Heterogeneity in the processing defect of SLC26A4 mutants. J. Med. Genet. 2008, 45:411-419.
59. Yoshida A., Hisatome I., Taniguchi S., Shirayoshi Y., Yamamoto Y., Miake J., Ohkura T., Akama T., Igawa O., Shigemasa C., Kamijo K., Ikuyama S., Caturegli P., Suzuki K. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 2009, 94(2):442-448.